investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Hans Schreiber

Immunology of Unique Tumor Specific Antigens

Trachea, bronchus and lung

Jun Qin

Signaling Networks of Nuclear Receptor Transcriptional Crosstalk in Lung Cancer

Trachea, bronchus and lung

Xifeng Wu

Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes

Trachea, bronchus and lung

Jeffrey Schlom

Human Immune Responses to Tumor Antigens for Cancer Vaccine Development

Trachea, bronchus and lung

Pathology

Sherry L Emery

Tobacco Control in a Rapidly Changing Media Environment

Trachea, bronchus and lung

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Pasi A Janne

Targeting ALK and ROS1 in Lung Cancer

Trachea, bronchus and lung

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung

Uwe Rix

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Trachea, bronchus and lung

Pathology